pyruvaldehyde has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dube, G | 1 |
| Tiamiou, A | 1 |
| Bizet, M | 1 |
| Boumahd, Y | 1 |
| Gasmi, I | 1 |
| Crake, R | 1 |
| Bellier, J | 1 |
| Nokin, MJ | 2 |
| Calonne, E | 1 |
| Deplus, R | 1 |
| Wissocq, T | 1 |
| Peulen, O | 2 |
| Castronovo, V | 2 |
| Fuks, F | 1 |
| Bellahcène, A | 2 |
| Roy, A | 1 |
| Ahir, M | 1 |
| Bhattacharya, S | 1 |
| Parida, PK | 1 |
| Adhikary, A | 1 |
| Jana, K | 1 |
| Ray, M | 1 |
| Chiavarina, B | 1 |
| Durieux, F | 1 |
| Bianchi, E | 1 |
| Turtoi, A | 1 |
| Peixoto, P | 1 |
| Irigaray, P | 1 |
| Uchida, K | 1 |
| Belpomme, D | 1 |
| Delvenne, P | 1 |
3 other studies available for pyruvaldehyde and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Methylglyoxal: a novel upstream regulator of DNA methylation.
Topics: Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Pyruvaldehyde; Tr | 2023 |
Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cytochromes c; Drug Scre | 2017 |
Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes.
Topics: Arginine; Cell Line, Tumor; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; | 2014 |